Search Results - "Suzanne Craft"

Refine Results
  1. 1

    Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches by Kellar, Derek, Craft, Suzanne

    Published in Lancet neurology (01-09-2020)
    “…Insulin is a peptide secreted by the pancreas and plays an important role in the regulation of glucose metabolism in peripheral tissues. Although the role of…”
    Get full text
    Journal Article
  2. 2

    Insulin resistance and AD—extending the translational path by Craft, Suzanne

    Published in Nature reviews. Neurology (01-07-2012)
    “…Two recent studies have carefully characterized amyloid-related brain insulin resistance in animal models of, and patients with, Alzheimer disease (AD). The…”
    Get full text
    Journal Article
  3. 3

    Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment by Craft, Suzanne

    Published in Current Alzheimer research (01-04-2007)
    “…Insulin modulates cognition and other aspects of normal brain function. Insulin resistance is characterized by chronic peripheral insulin elevations, and it is…”
    Get more information
    Journal Article
  4. 4

    Insulin Resistance and Alzheimer's Disease: Bioenergetic Linkages by Neth, Bryan J, Craft, Suzanne

    Published in Frontiers in aging neuroscience (31-10-2017)
    “…Metabolic dysfunction is a well-established feature of Alzheimer's disease (AD), evidenced by brain glucose hypometabolism that can be observed potentially…”
    Get full text
    Journal Article
  5. 5

    Insulin resistance syndrome and Alzheimer's disease: Age- and obesity-related effects on memory, amyloid, and inflammation by Craft, Suzanne

    Published in Neurobiology of aging (01-12-2005)
    “…Insulin plays an important role in memory and other aspects of brain function. The insulin resistance syndrome, characterized by chronic peripheral insulin…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums by Arnold, Steven E., Arvanitakis, Zoe, Macauley-Rambach, Shannon L., Koenig, Aaron M., Wang, Hoau-Yan, Ahima, Rexford S., Craft, Suzanne, Gandy, Sam, Buettner, Christoph, Stoeckel, Luke E., Holtzman, David M., Nathan, David M.

    Published in Nature reviews. Neurology (01-03-2018)
    “…Key Points The molecular signalling pathways through which insulin exerts its actions in the body also mediate its roles in synaptic neurotransmission,…”
    Get full text
    Journal Article
  7. 7

    Diabetic Microvascular Disease: An Endocrine Society Scientific Statement by Barrett, Eugene J, Liu, Zhenqi, Khamaisi, Mogher, King, George L, Klein, Ronald, Klein, Barbara E K, Hughes, Timothy M, Craft, Suzanne, Freedman, Barry I, Bowden, Donald W, Vinik, Aaron I, Casellini, Carolina M

    “…Abstract Both type 1 and type 2 diabetes adversely affect the microvasculature in multiple organs. Our understanding of the genesis of this injury and of…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Enhancement of Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes by NOVAK, Vera, MILBERG, William, YING HAO, MUNSHI, Medha, NOVAK, Peter, GALICA, Andrew, MANOR, Bradley, ROBERSON, Paula, CRAFT, Suzanne, ABDULJALIL, Amir

    Published in Diabetes care (01-03-2014)
    “…To determine acute effects of intranasal insulin on regional cerebral perfusion and cognition in older adults with type 2 diabetes mellitus (DM). This was a…”
    Get full text
    Journal Article
  10. 10

    Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study by Nagpal, Ravinder, Neth, Bryan J., Wang, Shaohua, Mishra, Sidharth P., Craft, Suzanne, Yadav, Hariom

    Published in EBioMedicine (01-09-2020)
    “…Recently, we reported that patients with mild cognitive impairment (MCI) harbor specific signature of bacteria in their gut and that a modified Mediterranean…”
    Get full text
    Journal Article
  11. 11

    Intranasal Treatment of Central Nervous System Dysfunction in Humans by Chapman, Colin D., Frey, William H., Craft, Suzanne, Danielyan, Lusine, Hallschmid, Manfred, Schiöth, Helgi B., Benedict, Christian

    Published in Pharmaceutical research (01-10-2013)
    “…ABSTRACT One of the most challenging problems facing modern medicine is how to deliver a given drug to a specific target at the exclusion of other regions. For…”
    Get full text
    Journal Article
  12. 12

    Targeting immunometabolic pathways for combination therapy in Alzheimer's disease by Erichsen, Jennifer, Craft, Suzanne

    “…The recent success of disease‐modifying anti‐amyloid monoclonal antibodies in slowing Alzheimer's disease (AD) symptoms has been an exciting step forward for…”
    Get full text
    Journal Article
  13. 13

    Comparative Microbiome Signatures and Short-Chain Fatty Acids in Mouse, Rat, Non-human Primate, and Human Feces by Nagpal, Ravinder, Wang, Shaohua, Solberg Woods, Leah C, Seshie, Osborne, Chung, Stephanie T, Shively, Carol A, Register, Thomas C, Craft, Suzanne, McClain, Donald A, Yadav, Hariom

    Published in Frontiers in microbiology (30-11-2018)
    “…Gut microbiome plays a fundamental role in several aspects of host health and diseases. There has been an exponential surge in the use of animal models that…”
    Get full text
    Journal Article
  14. 14

    A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease by Turner, R Scott, Thomas, Ronald G, Craft, Suzanne, van Dyck, Christopher H, Mintzer, Jacobo, Reynolds, Brigid A, Brewer, James B, Rissman, Robert A, Raman, Rema, Aisen, Paul S

    Published in Neurology (20-10-2015)
    “…OBJECTIVE:A randomized, placebo-controlled, double-blind, multicenter 52-week phase 2 trial of resveratrol in individuals with mild to moderate Alzheimer…”
    Get full text
    Journal Article
  15. 15

    Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence by Freiherr, Jessica, Hallschmid, Manfred, Frey, William H., Brünner, Yvonne F., Chapman, Colin D., Hölscher, Christian, Craft, Suzanne, De Felice, Fernanda G., Benedict, Christian

    Published in CNS drugs (01-07-2013)
    “…Research in animals and humans has associated Alzheimer’s disease (AD) with decreased cerebrospinal fluid levels of insulin in combination with decreased…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer’s disease: a randomized trial by Kellar, Derek, Register, Thomas, Lockhart, Samuel N., Aisen, Paul, Raman, Rema, Rissman, Robert A., Brewer, James, Craft, Suzanne

    Published in Scientific reports (25-01-2022)
    “…Intranasal insulin (INI) has shown promise as a treatment for Alzheimer’s disease (AD) in pilot clinical trials. In a recent phase 2 trial, participants with…”
    Get full text
    Journal Article
  19. 19

    Insulin resistance predicts brain amyloid deposition in late middle-aged adults by Willette, Auriel A, Johnson, Sterling C, Birdsill, Alex C, Sager, Mark A, Christian, Bradley, Baker, Laura D, Craft, Suzanne, Oh, Jennifer, Statz, Eric, Hermann, Bruce P, Jonaitis, Erin M, Koscik, Rebecca L, La Rue, Asenath, Asthana, Sanjay, Bendlin, Barbara B

    Published in Alzheimer's & dementia (01-05-2015)
    “…Abstract Background Insulin resistance (IR) increases Alzheimer's disease (AD) risk. IR is related to greater amyloid burden post-mortem and increased…”
    Get full text
    Journal Article
  20. 20